CD3 downregulation identifies high-avidity human CD8 T cells
Clinical and Experimental Immunology · 2024
DOI: 10.1093/cei/uxad124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Genevieve T Clutton und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
CD8 T cells recognize infected and cancerous cells via their T-cell receptor (TCR), which binds peptide–MHC complexes on the target cell. The affinity of the interaction between the TCR and peptide–MHC contributes to the antigen sensitivity, or functional avidity, of the CD8 T cell. In response to peptide–MHC stimulation, the TCR–CD3 complex and CD8 co-receptor are downmodulated. We quantified CD3 and CD8 downmodulation following stimulation of human CD8 T cells with CMV, EBV, and HIV peptides spanning eight MHC restrictions, observing a strong correlation between the levels of CD3 and CD8 downmodulation and functional avidity, regardless of peptide viral origin. In TCR-transduced T cells targeting a tumor-associated antigen, changes in TCR-peptide affinity were sufficient to modify CD3 and CD8 downmodulation. Correlation analysis and generalized linear modeling indicated that CD3 downmodulation was the stronger correlate of avidity. CD3 downmodulation, simply measured using flow cytometry, can be used to identify high-avidity CD8 T cells in a clinical context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
ORCID-Profile: Genevieve T Clutton
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
- University of North Carolina at Chapel Hill Center
Zitieren
APA
Clutton, G. T., Weideman, A. M. K., Mischell, M. A., Kallon, S., Conrad, S. Z., Shaw, F. R., Warren, J. A., Lin, L., Kuruc, J. D., Xu, Y., Gay, C. M., Armistead, P. M., G Hudgens, M., & Goonetilleke, N. P. (2024). CD3 downregulation identifies high-avidity human CD8 T cells. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxad124
Vancouver
Clutton GT, Weideman AMK, Mischell MA, Kallon S, Conrad SZ, Shaw FR, et al. CD3 downregulation identifies high-avidity human CD8 T cells. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxad124
BibTeX
@article{Clutton2024,
author = {Clutton, Genevieve T and Weideman, Ann Marie K and Mischell, Melissa A and Kallon, Sallay and Conrad, Shayla Z and Shaw, Fiona R and Warren, Joanna A and Lin, Lin and Kuruc, JoAnn D and Xu, Yinyan and Gay, Cynthia M and Armistead, Paul M and G Hudgens, Michael and Goonetilleke, Nilu P},
title = {CD3 downregulation identifies high-avidity human CD8 T cells},
journal = {Clinical and Experimental Immunology},
year = {2024},
doi = {10.1093/cei/uxad124}
}
EUVIMED